<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-20 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-20/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-20"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-20 ä»Šæ—¥ç­›é€‰å‡º 123 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-20T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-20T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week472025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-20"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-20 ä»Šæ—¥ç­›é€‰å‡º 123 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-20T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-20T00:00:00+00:00"><meta itemprop=wordCount content="3147"><meta itemprop=keywords content="Research,Daily,Week472025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-20"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-20 ä»Šæ—¥ç­›é€‰å‡º 123 æ¡å†…å®¹ï¼Œæ¥è‡ª 4 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-20</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-20T00:00:00Z>2025-11-20</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-20>ğŸ“… Daily Report - 2025-11-20</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>123</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
å•ç»†èƒå¤šç»„å­¦æŠ€æœ¯çªç ´ï¼Œç»“åˆDNAç”²åŸºåŒ–å’Œç»„è›‹ç™½ä¿®é¥°ï¼Œé¦–æ¬¡åŠ¨æ€é‡å»ºè¡¨è§‚åŸºå› ç»„ç»´æŒè¿‡ç¨‹ï¼›ä¸­å›½ç§‘å­¦å®¶å‘æ˜é€šç”¨å‹æŠ—ç™Œå…ç–«ç–—æ³•ï¼Œè¯±å¯¼ç‰¹å¼‚æ€§Tç»†èƒæ€ç­ç™Œç»†èƒã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>è¡¨è§‚é—ä¼ å­¦ä¸ç–¾ç—…æœºåˆ¶</strong>ï¼šè§£æä»£è°¢å¼‚å¸¸ä¸è¡¨è§‚é—ä¼ è°ƒæ§å¤šå›Šåµå·¢ç»¼åˆå¾ï¼ˆPCOSï¼‰çš„æ–°æœºåˆ¶ï¼Œæ­ç¤ºPKM2ä»‹å¯¼ç»„è›‹ç™½ä¹³é…¸åŒ–åœ¨PCOSä¸­çš„å…³é”®ä½œç”¨ï¼›ç ”ç©¶å…¨åŸºå› ç»„å€å¢ï¼ˆWGDï¼‰åœ¨è‚¿ç˜¤è¿›å±•ä¸­çš„æ¼”åŒ–åŠ¨æ€ã€‚</li><li><strong>å…ç–«ä¸è‚¿ç˜¤æ²»ç–—</strong>ï¼šå¼€å‘æ–°å‹æŠ—ç™Œå…ç–«ç–—æ³•ï¼Œä½¿ç™Œç»†èƒè¡¨è¾¾å¤–æºæ€§æŠ—åŸè¯±å¯¼ç‰¹å¼‚æ€§Tç»†èƒæ€ç­ï¼›æ¢ç´¢è‚¿ç˜¤çªå˜å¦‚ä½•å¼•çˆ†å…ç–«æ²»ç–—æ•ˆæœï¼›ç ”ç©¶è‚ é“å¾®ç”Ÿç‰©ç»„ä¸è‡ªé—­ç—‡çš„å…³è”ï¼ˆç¼ºä¹ç§‘å­¦è¯æ®ï¼‰ã€‚</li><li><strong>å•ç»†èƒæŠ€æœ¯ä¸åº”ç”¨</strong>ï¼šåˆ©ç”¨å•ç»†èƒå¤šç»„å­¦ï¼ˆå«ç©ºè½¬ã€ä»£è°¢ç»„ï¼‰å‘æ˜ç§‘ç ”äº®ç‚¹ï¼›æ„å»ºåŠ¨æ€åŸºå› è¡¨è¾¾å›¾è°±æ•°æ®åº“ï¼ˆDynamic BodyMapï¼‰ï¼›ç»˜åˆ¶å¤§è§„æ¨¡Tç»†èƒå›¾è°±ï¼Œä¸ºç”Ÿç‰©ä¿¡æ¯å­¦æ³¨é‡Šæä¾›â€œé»„é‡‘æ ‡å°ºâ€ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å•ç»†èƒå¤šç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆDNAç”²åŸºåŒ–ã€ç»„è›‹ç™½ä¿®é¥°ã€RNAæµ‹åºç­‰ï¼Œå®ç°å¯¹è¡¨è§‚åŸºå› ç»„åŠ¨æ€è¿‡ç¨‹çš„ç²¾ç»†è§£æã€‚</li><li><strong>æ–°å‹æŠ—ç™Œç­–ç•¥</strong>ï¼šé€šè¿‡â€œå«ç¥¸â€ç­–ç•¥ï¼Œè®©ç™Œç»†èƒè¡¨è¾¾å¤–æºæ€§æŠ—åŸï¼Œå®ç°ç²¾å‡†å…ç–«æ€ä¼¤ã€‚</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºäº†èƒ¶è´¨æ¯ç»†èƒç˜¤ä¸­å…·æœ‰æŠ—è‚¿ç˜¤æ´»æ€§çš„è›‹ç™½æ¿€é…¶CÎ´è¡¨è¾¾çš„å¾®èƒ¶è´¨ç»†èƒã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>ç™Œç—‡å…ç–«ç–—æ³•ï¼šé¶å‘SCUBE3ã€DPP4ã€CAR-Tç»†èƒã€å†…æºæ€§é€†è½¬å½•ç—…æ¯’ã€FSTL3ã€KRASä¿¡å·é€šè·¯ã€EZH2æŠ‘åˆ¶å‰‚ã€ä»¥åŠCDKæŠ‘åˆ¶å‰‚ï¼Œä»¥å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«å’Œæ²»ç–—æ•ˆæœã€‚</li><li>ç‚ç—‡ä¸ä»£è°¢æ€§ç–¾ç—…ï¼šç ”ç©¶è‚¥èƒ–é©±åŠ¨çš„2å‹ç³–å°¿ç—…ï¼Œä»¥åŠé«˜è¡€å‹å¯¹æµ·é©¬ç‚ç—‡å’Œè®¤çŸ¥åŠŸèƒ½çš„å½±å“ã€‚</li><li>å…ç–«ç»†èƒè°ƒæ§ï¼šæ¢ç´¢Tç»†èƒåˆ†åŒ–ã€NKç»†èƒæ¿€æ´»ã€ä»¥åŠå£è…”ç²˜è†œå…ç–«çš„æœºåˆ¶ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç©ºé—´è½¬å½•ç»„å­¦ï¼šå®ç°ç»†èƒåˆ†è¾¨ç‡ä¸‹çš„åŸºå› è¡¨è¾¾å’Œç©ºé—´å®šä½åˆ†æã€‚</li><li>Ribo-liteæ–¹æ³•ï¼šé¦–æ¬¡å®ç°ä½è¾“å…¥é‡ä¸‹AMLç»†èƒçš„è½¬å½•ç»„å’Œç¿»è¯‘ç»„é…å¯¹åˆ†æã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ­ç¤ºäº†è‚¿ç˜¤èµ·å§‹é˜¶æ®µå·¨å™¬ç»†èƒæåŒ–é©±åŠ¨å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒçš„æœºåˆ¶ï¼Œå¹¶æ¢ç´¢äº†åŒç‰¹å¼‚æ€§æŠ—ä½“ç»“åˆçº³ç±³æŠ€æœ¯åœ¨ç™Œç—‡å…ç–«æ²»ç–—ä¸­çš„ååŒå¢æ•ˆæ½œåŠ›ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å¾®ç¯å¢ƒè°ƒæ§ï¼šç ”ç©¶EGFRé©±åŠ¨è‚ºè…ºç™Œèµ·å§‹é˜¶æ®µï¼Œå·¨å™¬ç»†èƒå¦‚ä½•é€šè¿‡BMP2/4-ACVR1ä¿¡å·æåŒ–ï¼Œå½¢æˆå…ç–«æŠ‘åˆ¶æ€§å¾®ç¯å¢ƒã€‚</li><li>ç™Œç—‡å…ç–«æ²»ç–—ç­–ç•¥ï¼šå¼€å‘ç»“åˆçº³ç±³æŠ€æœ¯ä¸åŒç‰¹å¼‚æ€§æŠ—ä½“ï¼ˆbsAbï¼‰çš„æ–°å‹ç–—æ³•ï¼Œä»¥æå‡ç–—æ•ˆå¹¶é™ä½æ¯’æ€§ã€‚</li><li>è¯ç‰©è€è¯æœºåˆ¶è§£æï¼šåˆ©ç”¨CRISPR-Cas9æŠ€æœ¯ï¼Œè¯†åˆ«èƒ°è…ºç™Œä¸­KRASæŠ‘åˆ¶å‰‚çš„è€è¯æœºåˆ¶ã€‚</li><li>è‚¿ç˜¤ä»£è°¢ä¸è¿›å±•ï¼šç ”ç©¶çº¿ç²’ä½“è½¬ç§»å¦‚ä½•æŒ½æ•‘çº¿ç²’ä½“DNAç¼ºé™·ç™Œç»†èƒçš„å‘¼å¸åŠŸèƒ½ï¼Œæ”¯æŒå˜§å•¶åˆæˆå¹¶ä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿ã€‚</li><li>ä¿¡å·é€šè·¯é¶å‘æ²»ç–—ï¼šé‰´å®šp300æ˜¯IRF4çš„å…³é”®å…±æ¿€æ´»å‰‚ï¼Œå¹¶å°†å…¶ä½œä¸ºé¶ç‚¹æ²»ç–—å¤šå‘æ€§éª¨é«“ç˜¤ã€‚</li><li>è‚¿ç˜¤è½¬ç§»æœºåˆ¶ï¼šé˜æ˜GRPRé€šè·¯æ¿€æ´»FAM135Aï¼Œé©±åŠ¨å‰åˆ—è…ºç™Œçš„ç¥ç»å‘¨æµ¸æ¶¦ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å•ç»†èƒRNAæµ‹åºï¼šç”¨äºè¡¨å¾è‚¿ç˜¤èµ·å§‹é˜¶æ®µå…ç–«å¾®ç¯å¢ƒçš„æ—¶é—´åŠ¨æ€ã€‚</li><li>CRISPR-Cas9åŸºå› ç¼–è¾‘ï¼šç”¨äºç³»ç»Ÿæ€§ç­›æŸ¥KRASæŠ‘åˆ¶å‰‚è€è¯æœºåˆ¶ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
äºšé©¬é€Šèå­æ¯’æ¶²å±•ç°å‡ºå¯¹æŠ—ä¹³è…ºç™Œçš„å¼ºå¤§æ½œåŠ›ï¼Œå…¶åˆ†å­èƒ½æœ‰æ•ˆæ€ç­ç™Œç»†èƒã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>åˆ©ç”¨å¤©ç„¶æ¯’æ¶²æˆåˆ†ï¼ˆå¦‚äºšé©¬é€Šèå­æ¯’æ¶²ï¼‰å¼€å‘æ–°å‹æŠ—ç™Œç–—æ³•ã€‚</li><li>ç»“åˆæ”¾å°„æ€§åŒä½ç´ ã€å·¥ç¨‹è›‹ç™½å’Œäººå·¥æ™ºèƒ½ï¼Œæ„å»ºå¤šç»´åº¦ç™Œç—‡æ²»ç–—å·¥å…·ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>é¦–æ¬¡å‘ç°å¹¶åˆ©ç”¨äºšé©¬é€Šèå­æ¯’æ¶²ä¸­çš„ç‰¹å®šåˆ†å­ï¼Œå®ç°å¯¹ä¹³è…ºç™Œç»†èƒçš„é«˜æ•ˆæ€ç­ã€‚</li><li>åˆ›æ–°æ€§åœ°å°†ä¸åŒé¢†åŸŸçš„å…ˆè¿›æŠ€æœ¯ï¼ˆæ¯’æ¶²ã€åŒä½ç´ ã€å·¥ç¨‹è›‹ç™½ã€AIï¼‰æ•´åˆï¼Œä»¥æœŸå®ç°æ›´æœ‰æ•ˆçš„ç™Œç—‡æ²»ç–—ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (31æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>å•èƒå¤šç»„ | Nat.Methods | å•ç»†èƒå¤šç»„å­¦æ£€æµ‹DNAç”²åŸºåŒ–å’Œç»„è›‹ç™½ä¿®é¥°é‡å»ºè¡¨è§‚åŸºå› ç»„ç»´æŒçš„åŠ¨æ€è¿‡ç¨‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šBioJournal Link</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTç»†èƒã€å•ç»†èƒã€åŸºå› ç»„ã€è¡¨è§‚åŸºå› ç»„ã€ç”²åŸºåŒ–ã€ç»„è›‹ç™½</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg5NjgxNjkwOA==&amp;mid=2247503136&amp;idx=1&amp;sn=cb48e0e04f9e51a1bc3ad0af0f4957da">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>30+å•ç»†èƒå¤šç»„å­¦é€šè¿‡è§£æDNAç”²åŸºåŒ–ä¸ç»„è›‹ç™½ä¿®é¥°ï¼Œé‡æ„è¡¨è§‚åŸºå› ç»„ç»´æŒçš„åŠ¨æ€è¿‡ç¨‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä½œå›¾ä¸«</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€åŸºå› ç»„ã€è¡¨è§‚åŸºå› ç»„ã€ç”²åŸºåŒ–ã€ç»„è›‹ç™½</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šæœ€è¿‘æœ‰å°ä¼™ä¼´åæ˜ æ”¶ä¸åˆ°æ¨é€ï¼Œå› ä¸ºå…¬ä¼—å·æ”¹äº†æ¨é€ç®—æ³•ï¼Œç°åœ¨éœ€è¦åŠ æ˜Ÿæ ‡ï¼Œå¤šç‚¹èµã€ç‚¹åœ¨çœ‹ï¼Œæ‰èƒ½å‡†æ—¶æ”¶åˆ°æ¨é€å“¦ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523442&amp;idx=1&amp;sn=0d9eb2d0ab6262731fc7aa7849d19b11">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>NBEï¼šå«ç¥¸ç™Œç»†èƒï¼ä¸­å›½ç§‘å­¦å®¶å‘æ˜é€šç”¨å‹æŠ—ç™Œå…ç–«ç–—æ³•ï¼Œè®©ç™Œç»†èƒè¡¨è¾¾ä¹™è‚ç—…æ¯’æŠ—åŸï¼Œè¯±å¯¼ç‰¹å¼‚æ€§Tç»†èƒæ€ç­ç™Œç»†èƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå¥‡ç‚¹è‚¿ç˜¤æ¢ç§˜</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€Tç»†èƒã€Bç»†èƒã€æŠ—åŸ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šæå¾—ç™Œç»†èƒâ€œä¸€å¤´é›¾æ°´â€ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI4ODc5MDI5NA==&amp;mid=2247503519&amp;idx=1&amp;sn=d98e7f56087dc065f00aa0b1617ea245">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>é»„è·å‡¤é™¢å£«é¢†è¡”ï¼æ­ç¤ºä»£è°¢å¼‚å¸¸ä¸è¡¨è§‚é—ä¼ äº¤å‰è°ƒæ§å¤šå›Šåµå·¢ç»¼åˆå¾æ–°æœºåˆ¶ï¼ŒPKM2ä»‹å¯¼çš„ç»„è›‹ç™½ä¹³é…¸åŒ–æˆ–æ˜¯å…³é”®è‡´ç—…å› ç´ </strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šè½¬åŒ–åŒ»å­¦ç½‘</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢ã€ä»£è°¢ç»„ã€è¡¨è§‚é—ä¼ ã€ç»„è›‹ç™½</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šé¦–æ¬¡æ­ç¤ºä¸™é…®é…¸æ¿€é…¶M2ï¼ˆPKM2ï¼‰é€šè¿‡æ ¸æ˜“ä½ä¿ƒè¿›ç»„è›‹ç™½ä¹³é…¸åŒ–ä¿®é¥°ï¼Œé‡æ„ä¸‰ç»´åŸºå› ç»„ç»“æ„ï¼Œä»è€Œæ¿€æ´»PCOSå…³é”®è‡´ç—…åŸºå› çš„è¡¨è¾¾ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510197&amp;idx=1&amp;sn=40745a3357e49489522fca9b7c14c7b0">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>å•ç»†èƒ+ç©ºè½¬+ä»£è°¢ç»„ï¼Œå…¬å¼€æ•°æ®é›†æ‰¾å‡ºäº®ç‚¹å°±èƒ½å‘1åŒº12åˆ†</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡äºº</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢ã€ä»£è°¢ç»„ã€å•ç»†èƒ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248620&amp;idx=8&amp;sn=14c85fcac6895fb3b909833fc2e3b523">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>Cancer Cellé‡ç£…ï¼šè‚¿ç˜¤ç«Ÿè¢«è‡ªå·±äººèƒŒåˆºï¼çªå˜å¼•çˆ†å…ç–«æ²»ç–—</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡äºº</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€cancerã€å…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼š10æœˆ16æ—¥ï¼ŒCancer Cellå‘è¡¨äº†å¾·å·å¤§å­¦MDå®‰å¾·æ£®ç™Œç—‡ä¸­å¿ƒPadmanee Sharmaæ•™æˆå›¢é˜Ÿçš„é‡</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248620&amp;idx=3&amp;sn=5fa0f83bb7f0423626ef7f9308fc9aa0">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>è„šæœ¬æ›´æ–°&ndash;ä½ç²¾åº¦ï¼ˆvisiumã€stereo-seq bin > 50ï¼‰çš„ç»†èƒé‚»åŸŸåˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒç©ºé—´äº¤å“ä¹</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTç»†èƒã€Bç»†èƒã€Visium</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè„šæœ¬æ›´æ–°&ndash;ä½ç²¾åº¦ï¼ˆvisiumã€stereo-seq bin > 50ï¼‰çš„ç»†èƒé‚»åŸŸåˆ†æ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247499021&amp;idx=1&amp;sn=5f242254f361807de74dde90be1f129f">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>Dynamic-BW - åŠ¨æ€åŸºå› è¡¨è¾¾å›¾è°±ã€å›½å®¶ç”Ÿç‰©ä¿¡æ¯ä¸­å¿ƒã€‘</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡èœé¸Ÿå›¢</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç”Ÿç‰©ä¿¡æ¯ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šDynamic BodyMap æ˜¯ä¸€ä¸ªæ¶µç›–æ—¶é—´åºåˆ— RNA æµ‹åºæ•°æ®é›†ä¸­å¤šä¸ªç‰©ç§çš„æ•°æ®åº“ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247538150&amp;idx=1&amp;sn=78c679e0b70e921057f14b2be567ab32">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>ä»é›¶å¼€å§‹å­¦ä¹ å•ç»†èƒå…ç–«ç»„åº“ï¼ˆäºŒï¼‰ï¼šå­¦ä¼šæ·±å…¥è§£è¯»ç»“æœæ–‡ä»¶ï¼ï¼ˆæ–‡æœ«èµ ä¹¦æ´»åŠ¨ï¼‰</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡ä½œæ›²å®¶</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å•ç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç§‘å­¦ï¼Œå¾ªåºæ¸è¿›çš„å•ç»†èƒå…ç–«ç»„åº“æ•™ç¨‹</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI5ODI0NzM2OQ==&amp;mid=2247491587&amp;idx=1&amp;sn=7634669271cea10c34c80c27c4a54845">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>å¡‘é€ Tç»†èƒå‘½è¿çš„å…ç–«ç»†èƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šé—²è°ˆ Immunology</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€Tç»†èƒ</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2OTczNjI0OQ==&amp;mid=2247528930&amp;idx=1&amp;sn=014e1619800b30ecebd40dfef0cf0a56">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 21 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (85æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE298689 ç©ºé—´åˆ†è¾¨å•ç»†èƒåˆ†ææ­ç¤ºèƒ¶è´¨æ¯ç»†èƒç˜¤ä¸­å…·æœ‰æŠ—è‚¿ç˜¤æ´»æ€§çš„è›‹ç™½æ¿€é…¶ CÎ´ è¡¨è¾¾å°èƒ¶è´¨ç»†èƒ [ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€kinaseã€single-cellã€spatialã€spatiallyã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Reza Mirzaei ; Reid McNeil ; Charlotte Dâ€™Mello ; Britney Wong ; Susobhan Sarkar ; Frank Visser ; Candice Poon ; Pinaki Bose ; Wee YongSeries Type : OtherOrganism : Mus musculusThe glioblastoma (GBM) microenvironment contains resident immune cells with intrinsic anti-tumor potential, particularly microglia. Understanding the single-cell spatial heterogeneity and interactions between immune cells and brain tumorâ€“initiating cells (BTICs) is essential for identifying therapeutic targets to reprogram immune responses and suppress BTIC growth. Using single-cell and spatial transcriptomics, we mapped immune cell populations in the GBM microenvironment and identified signaling networks mediating immuneâ€“cancer cell interactions. We discovered a previously unrecognized subset of microglia expressing protein kinase CÎ´ (PKCÎ´) with anti-tumor activity against BTICs. The presence of PKCÎ´-expressing microglia was validated in human GBM specimens. Enhancing PKCÎ´ in microglia via adeno-associated virus or niacin increased phagocytosis of patient-derived BTICs in vitro and improved survival in GBM-bearing mice. Data from The Cancer Genome Atlas (TCGA) revealed that high PKCÎ´ expression correlates with increased apoptosis, phagocytosis, and immune signaling pathways. These findings offer highlight PKCÎ´+ microglia as a promising therapeutic target in GBM.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298689">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE298688 ç©ºé—´åˆ†è¾¨å•ç»†èƒåˆ†ææ­ç¤ºèƒ¶è´¨æ¯ç»†èƒç˜¤ä¸­å…·æœ‰æŠ—è‚¿ç˜¤æ´»æ€§çš„è›‹ç™½æ¿€é…¶ CÎ´ è¡¨è¾¾å°èƒ¶è´¨ç»†èƒ [scRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€kinaseã€single-cellã€scRNAã€spatially</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Reza Mirzaei ; Reid McNeil ; Charlotte Dâ€™Mello ; Britney Wong ; Susobhan Sarkar ; Frank Visser ; Candice Poon ; Pinaki Bose ; Wee YongSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe glioblastoma (GBM) microenvironment contains resident immune cells with intrinsic anti-tumor potential, particularly microglia. Understanding the single-cell spatial heterogeneity and interactions between immune cells and brain tumorâ€“initiating cells (BTICs) is essential for identifying therapeutic targets to reprogram immune responses and suppress BTIC growth. Using single-cell and spatial transcriptomics, we mapped immune cell populations in the GBM microenvironment and identified signaling networks mediating immuneâ€“cancer cell interactions. We discovered a previously unrecognized subset of microglia expressing protein kinase CÎ´ (PKCÎ´) with anti-tumor activity against BTICs. The presence of PKCÎ´-expressing microglia was validated in human GBM specimens. Enhancing PKCÎ´ in microglia via adeno-associated virus or niacin increased phagocytosis of patient-derived BTICs in vitro and improved survival in GBM-bearing mice. Data from The Cancer Genome Atlas (TCGA) revealed that high PKCÎ´ expression correlates with increased apoptosis, phagocytosis, and immune signaling pathways. These findings offer highlight PKCÎ´+ microglia as a promising therapeutic target in GBM.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298688">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE285952ï¼šå¯¹æ¥å—è¿‡ç»§æ€§pmel-1 Tç»†èƒæ²»ç–—æˆ–æœªæ²»ç–—çš„å°é¼ ï¼ˆæºå¸¦æ–°æŠ—åŸï¼ˆB16KVPï¼‰æˆ–é‡ç”Ÿå‹ï¼ˆB16F10ï¼‰è‚¿ç˜¤ï¼‰çš„è‚¿ç˜¤å’Œæ·‹å·´ç»“è¿›è¡ŒNanostringåˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€lymphã€T cellã€regex:lymph(o|atic)?</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Amalia Rivera Reyes ; Hannah M KnochelmannSeries Type : Expression profiling by arrayOrganism : Mus musculusTwo separate experiments were performed. Experiment 1: Mice were subcutaneously injected with either B16F10 or B16KVP tumors. 6 days later, they were given 5Gy total body irradiation as a lymphdepletion regimen. Then the next day, 500,000 naÃ¯ve pmel-1 CD8 T cells were injected via the tail vein into these mice. 5 days after adoptive cellular therapy, these mice were sacrified and the tumors and tumor draining lymph nodes harvested for Nanostring analysis. Experiment 2: Mice were subcutaneously injected with either B16F10 or B16KVP tumors. 6 days later, they were given 5Gy total body irradiation as a lymphdepletion regimen. Then the next day, mice were given no treatment or 500,000 naÃ¯ve pmel-1 CD8 T cells were injected via the tail vein into these mice. 5 days after adoptive cellular therapy, these mice were sacrified and the tumors harvested for Nanostring analysis.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285952">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE307425 æŠ—ä½“é¶å‘åˆ†æ³Œè›‹ç™½ SCUBE3 é€šè¿‡æŠ‘åˆ¶ä¿ƒè‚¿ç˜¤ä¿¡å·ä¼ å¯¼å’Œè¯±å¯¼æŠ—è‚¿ç˜¤å…ç–«æ¥æŠ‘åˆ¶ç™Œç—‡ç”Ÿé•¿å’Œè½¬ç§»</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€antibody</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Deepika Singh ; Benjamin C Onyeagucha ; Manjeet Rao ; Zhao Lai ; Yidong ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThrough a loss-of-function genomic screening approach, we identified Signal peptide CUB domain EGF-like 3 (SCUBE3) as a critical player for the survival and therapy resistance of cancer cells, particularly in triple negative breast cancer (TNBC). To further understand the mechanism by which SCUBE3 may support tumor growth and metastasis, we performed gene expression analysis on MDA-MB-231 cells stably silenced for SCUBE3. Pathway analysis reveled that Myc signaling, G2M checkpoint and DNA repair-associated genes were highly downregulated, while IFN gamma, inflammatory response and immunity-associated pathways were highly upregulated in SCUBE3-silenced TNBC cells.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307425">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE302247 äºŒè‚½åŸºè‚½é…¶ 4 çš„æ¢å¤ä¿ƒè¿› KRAS-LKB1 çªå˜å‹è‚ºç™Œçš„æŠ—è‚¿ç˜¤å…ç–«</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€KRAS</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Toshiyuki Tenma ; Ryohei Yoshida ; Hiraku Yanada ; Kiichi Nitanai ; Toshihiro Nagato ; Kyohei Oyama ; Nobunari Sasaki ; Mizuki Homme ; Chie Mori ; Takayuki Ohkuri ; Yusuke Ono ; Shoichiro Tange ; Yoshinori Minami ; Hiroya Kobayashi ; Yusuke Mizukami ; David A Barbie ; Shunsuke Kitajima ; Takaaki SasakiSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensKRAS proto-oncogene, GTPase (KRAS)-liver kinase B1 (LKB1)-mutant (KL) non-small cell lung cancer (NSCLC), characterized by a profoundly immunosuppressive tumor microenvironment (TME), is highly resistant to immune checkpoint inhibitors (ICIs). Despite their high tumor mutation burden, KL tumors exhibit low programmed cell death ligand 1 (PD-L1) expression, reduced immune cell infiltration, and suppressed immune signaling pathways. Through systematic genomic analyses, we found that LKB1 loss suppresses dipeptidyl peptidase 4 (DPP4) expression and activity in KRAS-mutant lung cancer. Therefore, we evaluated the therapeutic potential of restoring DPP4 function to improve the immune response in KL lung cancer using patient-derived tumor samples and syngeneic mouse models. Restoration of DPP4 expression reprogrammed the TME and significantly increased immune-related gene signatures, including those involved in T cell migration and natural killer (NK) cell activation. Indeed, DPP4 restoration in three-dimensional microfluidic models enhanced NK cell chemotaxis and activity in targeting tumor spheroids. Furthermore, DPP4 restoration in syngeneic KL murine models synergized with anti-PD-1 therapy to achieve significant tumor regression. These findings suggest that LKB1 loss suppresses DPP4 expression, contributing to the immunosuppressive characteristics of the TME in KL-NSCLC cells, whereas, restoring DPP4 expression promotes NK cell recruitment, facilitates immune activation, and enhances the effects of anti-PD-1 therapy. These results highlight DPP4 as a key immune modulator and a promising therapeutic target, offering a novel strategy to overcome immune resistance and enhance immunotherapy outcomes in this challenging subset of lung cancer.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302247">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE309948 åˆ†æ³Œæ¿€é…¶ FAM20C è§¦å‘è„‚è‚ªç»†èƒåŠŸèƒ½éšœç¢ï¼Œä»è€Œå¯¼è‡´è‚¥èƒ–ä¸­çš„èƒ°å²›ç´ æŠµæŠ—å’Œç‚ç—‡</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammationã€kinaseã€resistance</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusObesity is a major driver of type 2 diabetes (T2D) and related metabolic disorders, characterized by chronic inflammation and adipocyte dysfunction. However, the molecular triggers initiating these processes remain poorly understood. We identify FAM20C, a serine/threonine kinase, as an early obesity-induced mediator of adipocyte dysfunction. Fam20c expression is substantially upregulated in adipocytes in response to obesity, correlating with a proinflammatory transcriptional signature. Forced expression of Fam20c in adipocytes promotes robust upregulation of proinflammatory cytokines and induces insulin resistance that is dependent on its kinase activity. Conversely, deletion of adipocyte Fam20c after established obesity and hyperglycemia improves glucose tolerance, augments insulin sensitivity, and reduces visceral adiposity, without altering body weight. Phosphoproteomic studies reveal that FAM20C regulates phosphorylation of intracellular and secreted proteins, modulating pathways critical to inflammation, metabolism, and extracellular matrix remodeling. We identify FAM20C-dependent substrates, such as CNPY4, whose phosphorylation contributes to proinflammatory adipocyte signaling. Of translational relevance, we show that in humans visceral adipose FAM20C expression positively correlates with insulin resistance. Our findings establish FAM20C as an early regulator of obesity-induced adipocyte dysfunction and systemic metabolic impairment. Our studies provide proof of concept that inhibition of FAM20C may serve as a potential therapy for T2D by restoring adipocyte health.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309948">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE299929 ç ”ç©¶è¡¨æ˜ï¼Œæ³›ç»†èƒå‘¨æœŸè›‹ç™½ä¾èµ–æ€§æ¿€é…¶æŠ‘åˆ¶å‰‚æ˜¯ä¸€ç§æ½œåœ¨çš„è…ºæ ·å›Šæ€§ç™Œæ²»ç–—æ–¹æ³•ï¼Œå®ƒèƒ½ä¸‹è°ƒ MYB::NFIB èåˆåŸºå› å¹¶â€‹â€‹è¯±å¯¼è‚¿ç˜¤æ¶ˆé€€ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€carcinomaã€kinase</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Mattias K Andersson ; Junchi HuangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAdenoid cystic carcinoma (ACC) is a MYB-driven, aggressive glandular cancer with a poor long-term prognosis that is resistant to systemic therapies. Therefore, there is an urgent need to develop novel therapeutic strategies for these patients. An in vitro small-molecule inhibitor screen identified sensitivity of cultured ACC cells to pan-CDK inhibitors. We here used RNA-seq analysis to investigate the cell biological and molecular effects of treatment with the pan-CDK inhibitor dinaciclib in ACC cells from two different cases. Our results show that dinaciclib treatment led to a downregulation of genes involved in cell cycle progression, DNA replication, and DNA repair. Upregulated genes affected programmed cell death and included genes involved in proteolysis and autophagy. ACC MYB signature genes were significantly downregulated in dinaciclib-treated ACC cells, indicating that dinaciclib perturbs MYB-driven gene expression.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299929">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE306418 è…¹ä¾§è§†ç½‘è†œçš„è¿›åŒ–é‡å¡‘ä½¿å››çœ¼é±¼ Anableps anableps å…·å¤‡ç©ºä¸­è§†è§‰ [ç©ºé—´è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Louise N. Perez ; Josane de Freitas Sousa ; Patricia SchneiderSeries Type : OtherOrganism : Anableps anablepsThe emergence of evolutionary novelties remains a central challenge in biology, particularly forcomplex organs such as the vertebrate eye. While visual systems have repeatedly undergonedegeneration or loss, examples of innovation are rare and poorly understood. Mechanistic insight intosuch gains requires tractable systems in which novel visual functions have evolved. Here we leverage thefour-eyed fish Anableps anableps to uncover the cellular and molecular basis of adaptation tosimultaneous aerial and aquatic light. Combining single-nucleus and spatial transcriptomics, we show thatthe Anableps ventral retina has been developmentally and functionally reconfigured for aerial vision. Infully aquatic teleosts such as zebrafish, ventral photoreceptors are tuned to red-shifted, downwelling light.In contrast, we show that Anableps exhibits an expanded and diversified ventral cone populationencompassing ultraviolet-, blue-, green-, and red-sensitive types, enabling broad-spectrum, high-intensityvision from above water. To estimate Anableps opsin spectral properties, we employed OPTICS, amachine-learning model of opsin spectral tuning, which predicts that the ventrally expressed opn1mw2opsin is red-shifted relative to typical green-sensitive pigments. Analysis of dorsal-ventral patterningmarkers reveals an overrepresentation of ventral retinal cell types. Consistent with this, comparativespatial transcriptomic profiling of developing and adult Anableps and the killifish (Fundulus heteroclitus)indicates a dorsal displacement of the dorsal-ventral boundary in Anableps, resulting in a proportionallylarger ventral retinal domain. Collectively, our results reveal that Anableps achieved its unique dual visualcapacity by developmentally expanding and functionally reprogramming the ventral retina for aerial lightdetection, an evolutionary innovation that redefines how retinal domains can adapt to radically differentvisual environments.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306418">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE305510 æ•´åˆç½‘ç»œè¯ç†å­¦ã€è½¬å½•ç»„å­¦å’Œå•ç»†èƒæµ‹åºæŠ€æœ¯æ¢è®¨æŸ”è‚å…‹åŠ›ç¼“è§£è‚ç¡¬åŒ–çš„ä½œç”¨</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cellã€transcriptomics</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chengbo Jin ; Tianle Ma ; Yiheng Zhang ; Xujing Gu ; Tong Zhu ; Xinyu Wu ; Xin Ding ; Suzhou Huang ; Yulan Wang ; Zhipeng Chen ; Huihua Fang ; Li WuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBackground: The progression of liver cirrhosis leads to severe complications, significantly threatening the survival and prognosis of patients. Rou gan ke li (Rgkl), a herbal formula derived from classical prescriptions, has used clinically over two decades and has good efficacy. However, its molecular mechanisms and active components remain undefined. Purpose: Exploring the molecular mechanisms of Rgkl in alleviating liver cirrhosis. Methods: CCl4-induced liver cirrhosis mice models were established. Liver stiffness and intrahepatic blood flow velocity were assessed using imaging. Serum ALT, AST, HA, and histopathology were analyzed. Hepatic stellate cells (HSCs) activation, liver sinusoidal endothelial cells (LSECs) fenestration, and angiogenesis were evaluated using immunohistochemistry and scanning electron microscopy. UPLC-Q-TOF-MS/MS and network pharmacology identified active components. Transcriptomics and single-cell sequencing identified key targets and pathways, validated via WB, immunofluorescence, and molecular docking. Results: Rgkl significantly reduced Liver stiffness and collagen deposition while increasing intrahepatic blood flow velocity in cirrhotic mice. Serum ALT, AST, and HA were markedly decreased. Rgkl inhibited Î±-SMA expression in HSC and downregulated pathological angiogenesis by reducing VEGF and CD34 expression. Additionally, Rgkl enhanced eNOS expression and preserved sinusoidal fenestration in LSEC. Furthermore, Rgkl ameliorated liver cirrhosis by modulating LSEC metabolic functions via the CD36/PPAR/CPT-1 pathway and suppressing HSC activation through the RhoA/ROCK/YAP and PI3K/AKT/NF-ÎºB pathways. Eighteen active components, such as Levistilide A and Quercetin, were strongly correlated with the amelioration of liver cirrhosis. Conclusions: Rgkl significantly attenuated hepatic injury and fibrosis. Mechanistically, Rgkl modulated LSEC lipid metabolism and phenotypic regulation, and suppressed HSC contraction and activation. Key active components contributing to these effects included Paeonilactone C, Levistilide A, and Quercetin.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305510">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE288271 å†…æºæ€§é€†è½¬å½•ç—…æ¯’é€šè¿‡ RIG-I é€šè·¯ä¿ƒè¿›ç³»ç»Ÿæ€§çº¢æ–‘ç‹¼ç–®ä¸­å¼‚å¸¸çš„ T ç»†èƒåˆ†åŒ– [å…¨è½¬å½•ç»„å­¦]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šT cellã€transcriptomicsã€pathway</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiaoli Min ; Yaqian Yu ; Zhi HuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe dysregulated differentiation of T lymphocytes play an important role in systemic lupus erythematosus (SLE). However, the underlying mechanism remains unclear. Here, we screened and identified many overexpressed HERVs in CD4+ T cells from SLE patients by whole transcriptome resequencing and found that some HERVs formed dsRNAs to induce the activation of the RIG-I signaling pathway. And our findings reveal the roles and mechanism of HERVs and RIG-I in regulating the aberrant differentiation of T cells in SLE patients.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288271">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 75 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (6æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨6æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨6æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>ç”± BMP2/4-ACVR1 ä¿¡å·ä»‹å¯¼çš„è‚¿ç˜¤å‰å·¨å™¬ç»†èƒæåŒ–ï¼Œåœ¨è‚¿ç˜¤èµ·å§‹è¿‡ç¨‹ä¸­è°ƒæ§å…ç–«æŠ‘åˆ¶å¾®ç¯å¢ƒ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€å…ç–«å¾®ç¯å¢ƒã€Bç»†èƒã€å·¨å™¬ç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç™Œç»†èƒèƒ½å¤Ÿé€šè¿‡åˆ¶é€ å…ç–«æŠ‘åˆ¶æ€§çš„â€œå†·â€è‚¿ç˜¤å¾®ç¯å¢ƒï¼ˆcTMEï¼‰æ¥è§„é¿å…ç–«ç›‘æµ‹ã€‚æ›´å¥½åœ°ç†è§£è‚¿ç˜¤å½¢æˆåˆæœŸ cTME å»ºç«‹æœºåˆ¶ï¼Œæœ‰åŠ©äºæ­ç¤ºæ›´ä¼˜çš„å…ç–«æ²»ç–—ç­–ç•¥ã€‚ä¸ºè¡¨å¾ cTME å½¢æˆçš„æ—¶é—´åŠ¨æ€ï¼Œæˆ‘ä»¬åœ¨ EGFR é©±åŠ¨è‚ºè…ºç™Œï¼ˆLUADï¼‰èµ·å§‹é˜¶æ®µç”Ÿæˆäº†å•ç»†èƒ RNA æµ‹åºæ•°æ®ã€‚TME ä¸­çš„å·¨å™¬ç»†èƒç»å†äº†ä»æŠ—è‚¿ç˜¤å·¨å™¬ç»†èƒå‘å‰è‚¿ç˜¤å·¨å™¬ç»†èƒçš„çŠ¶æ€è½¬å˜ï¼Œè¿™ä¿ƒæˆäº† cTME çš„å½¢æˆã€‚è‚¿ç˜¤ç»†èƒæ¥æºçš„ BMP2/4 è¯±å¯¼äº†å‰è‚¿ç˜¤å·¨å™¬ç»†èƒçš„æåŒ–ï¼Œä½¿ç”¨ ACVR1 æŠ‘åˆ¶å‰‚æŠ‘åˆ¶ BMP2/4-ACVR1 è½´ï¼Œå°† cTME è½¬åŒ–ä¸ºâ€œçƒ­â€TMEï¼ˆhTMEï¼‰ï¼Œä»è€Œæœ‰æ•ˆæŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿ã€‚æ­¤å¤–ï¼ŒEGFR çªå˜ LUAD æ‚£è€…è¡¨ç°å‡ºä¸å°é¼ è§‚å¯Ÿåˆ°çš„ cTME ç›¸ä¼¼ç‰¹å¾ï¼ŒACVR1 è¡¨è¾¾é«˜ä¸æ‚£è€…é¢„åè¾ƒå·®ç›¸å…³ã€‚æ€»ä½“è€Œè¨€ï¼Œé™¤äº†é˜æ˜å‰è‚¿ç˜¤å·¨å™¬ç»†èƒåœ¨ cTME å½¢æˆä¸­çš„ä½œç”¨å¤–ï¼Œæœ¬ç ”ç©¶è¿˜æ˜ç¡®å°† ACVR1 ä½œä¸ºæ²»ç–— EGFR çªå˜è‚ºç™Œçš„æ²»ç–—ç­–ç•¥ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1990852569088503808/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>åŒç‰¹å¼‚æ€§æŠ—ä½“ä¸çº³ç±³æŠ€æœ¯ï¼šç™Œç—‡å…ç–«æ²»ç–—ä¸­çš„æˆ˜ç•¥è”ç›Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€å…ç–«ã€æŠ—ä½“</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: åŒç‰¹å¼‚æ€§æŠ—ä½“ï¼ˆbsAbï¼‰æ—¨åœ¨è¯†åˆ«ä¸¤ç§ä¸åŒçš„æŠ—åŸæˆ–è¡¨ä½ï¼Œä½¿æ–°ä¸€ä»£ç™Œç—‡å…ç–«ç–—æ³•èƒ½å¤Ÿåˆ›æ–°åœ°å‘æŒ¥ä½œç”¨æœºåˆ¶ã€‚å°½ç®¡å…·æœ‰æ½œåŠ›ï¼ŒbsAb æ²»ç–—è¯ç‰©ä»é¢ä¸´ç”Ÿç‰©åˆ†å¸ƒå’Œè¯ä»£åŠ¨åŠ›å­¦æ–¹é¢çš„è¯¸å¤šæŒ‘æˆ˜ï¼Œå¸¸å¸¸å¯¼è‡´ç–—æ•ˆä¸æ¯’æ€§å¹³è¡¡ä¸ä½³ã€‚æœ¬ç»¼è¿°ä»ç®€è¦ä»‹ç» bsAbs åœ¨ç™Œç—‡å…ç–«æ²»ç–—ä¸­çš„ç›¸å…³æ€§å¼€å§‹ï¼Œæ—¨åœ¨æ‰¹åˆ¤æ€§åˆ†æçº³ç±³æŠ€æœ¯ä¸ bsAb æŠ€æœ¯åœ¨æå‡æ²»ç–—æ•ˆç‡åŒæ—¶é™ä½æ¯’æ€§æ–¹é¢çš„ååŒæ½œåŠ›ã€‚è¿™ç§ååŒæ•ˆåº”å¯ä»¥é€šè¿‡å¤šç§ç­–ç•¥å®ç°ï¼šï¼ˆiï¼‰bsAbs å¯èƒ½ä½œä¸ºé¶å‘é…ä½“ï¼Œæ”¹å–„è¯ç‰©è½½è·çº³ç±³è½½ä½“çš„ç”Ÿç‰©åˆ†å¸ƒ;ï¼ˆiiï¼‰å°†æ²»ç–—æ€§ bsAbs æºå…¥çº³ç±³è½½ä½“ï¼Œå¯èƒ½è½»æ¾å…‹æœç”Ÿç‰©å±éšœï¼Œè¾¾åˆ°ç›®æ ‡;ä»¥åŠï¼ˆiiiï¼‰bsAb å¯ä»¥é€šè¿‡ç¼–ç  mRNA è½½ä½“çš„çº³ç±³è½½ä½“åœ¨ä½“å†…ç”Ÿæˆã€‚æœ¬ç»¼è¿°æ¢è®¨äº†è¿™äº›æ–°å…´é¢†åŸŸçš„æŒ‘æˆ˜ï¼Œå¹¶ä¸ºè¯¥æœ‰å‰æ™¯é¢†åŸŸçš„æœªæ¥æ–¹å‘æä¾›äº†è§è§£ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1990847782355841024/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>CRISPR-Cas9 ç­›æŸ¥è¯†åˆ«èƒ°è…ºç™Œä¸­å¯¹ KRAS æŠ‘åˆ¶çš„è€è¯æœºåˆ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯ã€KRAS</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: é’ˆå¯¹å„ç§ KRAS çªå˜çš„ KRAS æŠ‘åˆ¶å‰‚ï¼ˆKRASiï¼‰å·²è¿›å…¥èƒ°è…ºç™Œä¸´åºŠè¯•éªŒã€‚å°½ç®¡åˆæ­¥ä¸´åºŠååº”æœ‰å¸Œæœ›ï¼Œå¤§å¤šæ•°æ‚£è€…å› å†…åœ¨æˆ–åå¤©æ€§è€è¯æ€§è€Œå¤å‘ã€‚å› æ­¤ï¼Œè”åˆæ²»ç–—å¯¹äºå»¶é•¿ KRAS é¶å‘ç–—æ³•çš„ç–—æ•ˆè‡³å…³é‡è¦ã€‚ä¸ºè¿›ä¸€æ­¥ç¡®å®š KRASi è€è¯æ€§çš„é—ä¼ æœºåˆ¶ï¼Œæˆ‘ä»¬åœ¨ KRASG12Dã€KRASG12Cã€KRASG12R å’Œ KRASQ61H çªå˜ PDAC ç»†èƒç³»ä¸­è¿›è¡Œäº† KRASi é”šå®šçš„ CRISPR-Cas9 åŠŸèƒ½ä¸§å¤±ç­›æŸ¥ï¼Œä½¿ç”¨å…­ä¸ª KRASiï¼Œä»¥è¯†åˆ«è°ƒèŠ‚å¯¹ KRAS æŠ‘åˆ¶æ•æ„Ÿæ€§çš„åŸºå› ã€‚é€šè¿‡è”åˆé¶å‘æŠ‘åˆ¶å‰‚ä¸ KRASiï¼ŒéªŒè¯äº†åŒ…æ‹¬ EGFRã€CK2ã€p110Î±å’Œ p110Î³ä»¥åŠ YAP åœ¨å†…çš„å¤šä¸ªç­›æŸ¥ç»“æœã€‚KRASQ61H çªå˜ PDAC ç»†èƒç³»å¯¹ KRAS çš„ç”Ÿå­˜ä¾èµ–æ€§æœ¬è´¨ä¸Šä½äºå…¶ä»– KRAS çªå˜äºšå‹ã€‚æ­¤å¤–ï¼ŒEGFR æŠ‘åˆ¶å‰‚å„æ´›æ›¿å°¼ä¸ RASï¼ˆONï¼‰å¤šé€‰æ‹©æ€§æŠ‘åˆ¶å‰‚ RMC-7977 åœ¨ KRASQ61H</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1990852560473403392/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>çº¿ç²’ä½“è½¬ç§»æŒ½æ•‘å‘¼å¸ï¼Œæ”¯æŒå˜§å•¶çš„ç”Ÿç‰©åˆæˆå’Œè‚¿ç˜¤è¿›å±•</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€çº¿ç²’ä½“</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: çº¿ç²’ä½“ DNAï¼ˆmtDNAï¼‰ä¸¥é‡ç¼ºé™·çš„ç™Œç»†èƒå¯ä»¥é€šè¿‡æ°´å¹³çº¿ç²’ä½“è½¬ç§»ï¼ˆHMTï¼‰å¯¼å…¥çº¿ç²’ä½“ä»¥æ¢å¤å‘¼å¸ã€‚çº¿ç²’ä½“å‘¼å¸å¯¹äºäºŒæ°¢é£Ÿæ°§é…¸è„±æ°¢é…¶ï¼ˆDHODHï¼‰çš„æ´»æ€§è‡³å…³é‡è¦ï¼ŒDHODH æ˜¯ä¸€ç§æ¥è‡ªçº¿ç²’ä½“å†…è†œçš„é…¶ï¼Œå‚¬åŒ–æ–°ç”Ÿå˜§å•¶åˆæˆçš„ç¬¬å››æ­¥ã€‚æœ¬ç ”ç©¶ç ”ç©¶äº†å˜§å•¶æ–°ç”Ÿåˆæˆåœ¨é©±åŠ¨çº¿ç²’ä½“ DNA ç¼ºä¹ï¼ˆÏ0ï¼‰ç»†èƒè‚¿ç˜¤ç”Ÿé•¿ä¸­çš„ä½œç”¨ã€‚è™½ç„¶åœ¨å°é¼ ä½“å†…ç§»æ¤çš„Ï0 ç»†èƒå®¹æ˜“è·å¾—çº¿ç²’ä½“ DNAï¼Œä½†åœ¨é‡‡ç”¨æ›¿ä»£æ°§åŒ–é…¶ï¼ˆAOXï¼‰è½¬æŸ“çš„ç»†èƒä¸­ï¼Œè¿™ä¸€è¿‡ç¨‹è¢«å»¶è¿Ÿï¼ŒAOX ç»“åˆäº†çº¿ç²’ä½“å‘¼å¸å¤åˆä½“ III å’Œ IV çš„åŠŸèƒ½ã€‚Ï0 AOX ç»†èƒå…·æœ‰ç³–è§£ä½œç”¨ï¼Œä½†ä¿æŒæ­£å¸¸çš„ DHODH æ´»æ€§å’Œå˜§å•¶çš„äº§ç”Ÿã€‚åœ¨ä¸€ç»„è‚¿ç˜¤ç»†èƒä¸­ DHODH çš„ç¼ºå¤±å®Œå…¨é˜»æ–­æˆ–å»¶ç¼“è‚¿ç˜¤ç”Ÿé•¿ã€‚è¿™äº›ç§»æ¤çš„Ï0 ç»†èƒè¿…é€Ÿæ‹›å‹Ÿäº†å…ˆå¤©å…ç–«ç³»ç»Ÿä¸­ä¿ƒè¿›è‚¿ç˜¤/ç¨³å®šçš„ç»†èƒï¼ŒåŒ…æ‹¬è‚¿ç˜¤å‰ M2 å·¨å™¬ç»†èƒã€ä¸­æ€§ç²’ç»†èƒã€å—œé…¸æ€§ç²’ç»†èƒå’Œé—´å……è´¨é—´è´¨ç»†èƒï¼ˆMSCsï¼‰ã€‚Ï0 ç»†èƒåœ¨ç§»æ¤åæ—©æœŸæ‹›å‹Ÿäº† MSCsï¼Œè¿™äº›</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1990852561190629376/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>å‚¬åŒ–æŠ‘åˆ¶ p300 ä¼˜å…ˆé’ˆå¯¹ IRF4 è‡´ç™Œæ´»æ€§å’Œå¤šå‘æ€§éª¨é«“ç˜¤è‚¿ç˜¤ç”Ÿé•¿</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: è‡´ç™Œè½¬å½•å› å­ï¼ˆTFï¼‰IRF4 æ˜¯ä¸€ç§ç›®å‰å°šæœªè¢«å®Œå…¨ç¡®å®šçš„æ™®éå¤šå‘æ€§éª¨é«“ç˜¤ï¼ˆMMï¼‰ä¾èµ–æ€§ã€‚é€šè¿‡è½¬å½•è°ƒæ§ç½‘ç»œï¼ˆTRNï¼‰å®šä½ï¼Œä¸€ç§æ— åå¤šç»„ç›®æ ‡è¯†åˆ«æ–¹æ³•ï¼Œæˆ‘ä»¬é‰´å®šå‡ºå…±æ¿€æ´»å‰‚èµ–æ°¨é…¸ä¹™é…°è½¬ç§»é…¶ï¼ˆKATï¼‰p300 ä½œä¸ºå…³é”®çš„ IRF4 ä¼™ä¼´ã€‚é€šè¿‡å®šé‡ç›¸äº’ä½œç”¨ç»„å›¾è°±éªŒè¯äº†è¿™ä¸€åå¥½å…³ç³»ï¼Œå‘ç° IRF4 æ˜¯ MM ç‰¹å¼‚æ€§ä¾èµ–æœ€ä¸°å¯Œçš„ï¼Œä¸”æ¯”å…¶ä»–è½¬å½•å› å­å¦‚ IKZF1/IKZF3 ä¸ p300 æ›´ä¸ºç´§å¯†å¤åˆã€‚ä¼˜åŒ–çš„ p300 èµ–æ°¨é…¸ä¹™é…°è½¬ç§»é…¶ï¼ˆKATï¼‰æŠ‘åˆ¶å‰‚ä½¿ IRF4 æ´»æ€§å’Œ MM å¢æ®–åœ¨ä½“å¤–å’Œä½“å†…å‡å¾—ä»¥æŠ‘åˆ¶ã€‚p300/CBP KAT æŠ‘åˆ¶ä¼˜å…ˆé’ˆå¯¹ MM ç»†èƒè€Œéæ­£å¸¸ç»†èƒï¼Œç‰¹å¼‚æ€§è°ƒèŠ‚ MM è½¬å½•ç»„ï¼Œä¸” p300 KAT æŠ‘åˆ¶å‰‚åœ¨è¾ƒä½æ°´å¹³ä¸‹æ›´å®Œå…¨æŠ‘åˆ¶ IRF4 æ´»æ€§ï¼Œç›¸è¾ƒäºç°æœ‰ p300/CBP æº´ç»“æ„åŸŸæŠ‘åˆ¶å‰‚ã€‚æ­¤å¤–ï¼Œç»“åˆ p300/CBP KAT æŠ‘åˆ¶å‰‚åŠæ²»ç–—æ–¹æ³•ï¼Œç»“åˆé’ˆå¯¹ MM è½¬å½•çš„æ­£äº¤æœºåˆ¶ï¼Œäº§ç”Ÿäº†ååŒæŠ—è‚¿ç˜¤æ•ˆåº”ã€‚è¿™äº›æ•°æ®å…±åŒæ¨åŠ¨äº†</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1990852569776369664/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>GRPR è¯±å¯¼çš„ FAM135A è¡¨è¾¾ä¿ƒè¿›å‰åˆ—è…ºç™Œçš„ç¥ç»å‘¨æµ¸æ¶¦</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç¥ç»</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç¥ç»å‘¨å›´æµ¸æ¶¦ï¼ˆPNIï¼‰æ˜¯å‰åˆ—è…ºç™Œï¼ˆPCaï¼‰è½¬ç§»çš„ç‹¬ç«‹ä¸è‰¯é¢„åæ ‡å¿—ç‰©ã€‚èƒƒæ³Œç´ é‡Šæ”¾è‚½å—ä½“ï¼ˆGRPRï¼‰é¶å‘å½±åƒå’Œæ²»ç–—å·²è¿›å…¥ä¸´åºŠè¯•éªŒé˜¶æ®µï¼Œå…¶åœ¨ PCa ç¥ç»å‘¨å›´ä¾µè¢­ä¸­çš„ä½œç”¨å°šä¸æ˜ç¡®ã€‚åœ¨è¿™é‡Œï¼Œæˆ‘ä»¬å‘ç°äº†åºåˆ—ç›¸ä¼¼åº¦ 135 çš„å®¶æ—æˆå‘˜ Aï¼ˆæˆå‘˜ Aï¼‰à¼ˆFAM135Aà¼‰a æ˜¾æ€§ PNI é©±åŠ¨ä½“ï¼Œåœ¨ PCa ä¸­è¢« GRPR æ¿€æ´»ã€‚é¦–å…ˆï¼ŒPNI-PCa ç»„ç»‡è¡¨ç°å‡ºæ›´é«˜çš„ç¥ç»æ´»æ€§é…ä½“-å—ä½“ç›¸äº’ä½œç”¨æ´»æ€§ï¼Œå…¶ä¸­ FAM135A æ˜¯ PNI ç»„ä¸­æœ€æ˜¾è‘—çš„æ ‡å¿—ã€‚éšåï¼Œä½“å¤–å®éªŒä½¿ç”¨ PCa ç»†èƒå…±åŸ¹å…»ç³»ç»Ÿï¼ˆåŒ…æ‹¬ AR é˜³æ€§ LNCaP å’Œ AR é˜´æ€§ DU145/PC3ï¼‰æ˜¾ç¤ºï¼Œæ¶ˆç­è‚¿ç˜¤æ¶æ€§è‚¿ç˜¤å’Œç¥ç»ä¾µè¢­ FAM135Aã€‚æ­¤å¤–ï¼Œä½“å†… PCa-åéª¨ç¥ç»ä¾µè¢­å°é¼ æ¨¡å‹æ˜¾ç¤º FAM135A æŠ‘åˆ¶èƒ½æ§åˆ¶è‚¿ç˜¤ç”Ÿé•¿å¹¶æ”¹å–„è¿åŠ¨åŠŸèƒ½ã€‚æœ‰è¶£çš„æ˜¯ï¼ŒFAM135A ç»†èƒæ ¸å¯Œé›†ï¼Œå…¶æ ¸æ˜“ä½ç”±è›‹ç™½è´¨ç»†èƒè´¨-æ ¸è½¬è¿è›‹ç™½ RAN ä»‹å¯¼ã€‚ä»æœºåˆ¶ä¸Šçœ‹ï¼ŒRNA-Seq</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1990847783047901184/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>äºšé©¬é€Šèæ¯’æ¶²å±•ç°å‡ºå¯¹æŠ—ä¹³è…ºç™Œçš„æƒŠäººåŠŸæ•ˆ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šScientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From Amazonian scorpions yielding molecules that kill breast cancer cells as effectively as chemotherapy, to improved fibrin sealants and custom-grown bioactive factors, researchers are pushing biotechnology into uncharted territory. Parallel teams are advancing radiotheranostics that diagnose and destroy tumors with precision, while others forge experimental vaccines that train the immune system using hybrid dendritic cells.</li><li>ğŸ”— <a href=https://www.sciencedaily.com/releases/2025/11/251117095658.htm>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>epigenetic</td><td>15</td></tr><tr><td>cancer</td><td>14</td></tr><tr><td>single-cell</td><td>10</td></tr><tr><td>RNA-seq</td><td>10</td></tr><tr><td>tumor</td><td>9</td></tr><tr><td>å…ç–«</td><td>8</td></tr><tr><td>kinase</td><td>7</td></tr><tr><td>ç”Ÿä¿¡</td><td>6</td></tr><tr><td>å•ç»†èƒ</td><td>6</td></tr><tr><td>Tç»†èƒ</td><td>6</td></tr><tr><td>T cell</td><td>6</td></tr><tr><td>transcriptomics</td><td>6</td></tr><tr><td>immune</td><td>6</td></tr><tr><td>sequencing</td><td>6</td></tr><tr><td>è‚¿ç˜¤</td><td>5</td></tr><tr><td>ChIP-seq</td><td>5</td></tr><tr><td>åŸºå› ç»„</td><td>5</td></tr><tr><td>inflammation</td><td>4</td></tr><tr><td>metabolic</td><td>4</td></tr><tr><td>pathway</td><td>4</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (21æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248620&amp;idx=5&amp;sn=90da95e0f3913c43f8c0e7b194686398">é¡¶åˆŠé‡Œç¨‹ç¢‘çªç ´ï¼å“ˆä½›å›¢é˜Ÿç»˜ 170 ä¸‡ T ç»†èƒå›¾è°±ï¼Œç”Ÿä¿¡æ³¨é‡Šæœ‰äº† â€œé»„é‡‘æ ‡å°ºâ€</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247658657&amp;idx=2&amp;sn=94186d6748a363a9627a882e213d3e4f">è‚ é“å¾®ç”Ÿç‰©ç»„ä¸è‡ªé—­ç—‡çš„å…³è”ç¼ºä¹ç§‘å­¦ä¾æ® | Cell Pressç§‘å­¦æ–°é—»</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU1MDk1NTY5MA==&amp;mid=2247540993&amp;idx=1&amp;sn=5e8ff9a87e006d4157230bb7bb3b484c">èµ‹èƒ½ä¸´åºŠç ”ç©¶ï¼šå•ç»†èƒæµ‹åºå…¥é—¨å¤§è®²å ‚</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI4MjY5ODI1Nw==&amp;mid=2247496736&amp;idx=1&amp;sn=6fe2f63e1e933071570e58a0e553b27b">å•ç»†èƒæµ‹åºå’Œæ·±åº¦å­¦ä¹ ç³»åˆ—äºŒï¼šdatasetçš„æ„å»ºå’Œç”¨é€”</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498506&amp;idx=1&amp;sn=df8d4ff334f64802da0a2912aa73f5d4">ç”Ÿä¿¡åˆ†æä¸€å®šè¦çœ‹ï¼PCAtoolsåŒ…ï¼Œä¸»æˆåˆ†åˆ†æä¸€é”®æå®šï¼Œè½»æ¾ç©è½¬åŸºå› è¡¨è¾¾æ•°æ®å¯è§†åŒ–ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495610&amp;idx=1&amp;sn=c365d9bf918bc975691b7e8c5e7892e6">å¤ç°äº†å‡ å¼ æ¼‚äº®çš„ç”Ÿä¿¡ç»„åˆå›¾ï¼Œç¤ºä¾‹æ•°æ®å’Œä»£ç éƒ½å¤‡å¥½äº†ï¼Œæ²¡é—®é¢˜ï¼Œéƒ½èƒ½è·‘é€š</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568962&amp;idx=2&amp;sn=e64360f3f5147bee1d15b202e61b6993">è®©ç™Œç»†èƒâ€œå†…è€—â€è‡³æ­»ï¼æ–°ç­–ç•¥æœ‰æœ›ç²¾å‡†æ¸…é™¤æ¶æ€§è‚¿ç˜¤</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzI5MDQzNjY2OA==&amp;mid=2247568962&amp;idx=1&amp;sn=5b2b8fce5aafa421acfa26def90913ba">ç§‘å­¦å®¶å‘ç°èƒ½å‡é‡çš„ç»†èŒï¼è‡ªè¡Œç”Ÿäº§â€œå‡è‚¥è¯â€ï¼Œæœ‰æœ›æŠµå¾¡é«˜è„‚é¥®é£Ÿå±å®³</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247547057&amp;idx=1&amp;sn=2a9d5d2ca495e5badef96d80eca2d251">ä»æ½œæ°´åˆ°åˆ†äº«ï¼šæˆ‘åœ¨ç”Ÿä¿¡ç¾¤é‡Œè¢«ç‚¹äº®çš„ä¸€ä¸ªæœˆ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzODIxMDY5NQ==&amp;mid=2247507389&amp;idx=2&amp;sn=0337559b5194e3fc3dcbb8b5863b3219">Nature | é­å®¶ç³ç­‰æ­ç¤ºåŠ¨ç‰©ä»æµ·æ´‹èµ°å‘é™†åœ°çš„åŸºå› ç»„ç§˜å¯†</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MTExNTkwNA==&amp;mid=2247573360&amp;idx=1&amp;sn=9e6cffd40f5feeb3162503e20cc86765">å¤§ä½¬æ˜¯æ€ä¹ˆç”¨TCGAæ•°æ®åšå…ç–«åˆ†æçš„ï¼Ÿ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248620&amp;idx=7&amp;sn=8c3b3511e60d88e9a3b8b46d11000687">Natureï¼šscWGS+scRNAè§£å¯†å…¨åŸºå› ç»„å€å¢çš„æ¼”åŒ–åŠ¨æ€</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248620&amp;idx=4&amp;sn=21d3fdb37841feedbdffeb2ebed65370">åˆ«å‚»äº†ï¼å¤šç»„å­¦åªåšå…³è”å’Œé€šè·¯ï¼Ÿè¿™æ³¢è¡€äºï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651248620&amp;idx=2&amp;sn=2bbc5947030c3468c489d2b967a3d8e2">é¢„åˆ¶èœæœ€åº”è¯¥å‡ºç°åœ¨ç”Ÿä¿¡é¢†åŸŸ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU1OTkyMTE4Mg==&amp;mid=2247488940&amp;idx=1&amp;sn=84f59eca845427584f788edc47e411ab">å¾€å¾€æ²¡æƒ³åˆ°ï¼Œèƒ°è…ºç‚ç«Ÿç„¶æ”¹å–„å…ç–«æ²»ç–—æ•ˆæœï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247658497&amp;idx=3&amp;sn=ef3ca291f782ccd30b173016537d2069">Mol Plantæœˆåº¦ä¸»ç¼–æ¨è | ä¸­å›½å†œå¤§ä¸æ¨æ—ç­‰æ­ç¤ºç»†èƒè†œå—ä½“å¤åˆä½“è°ƒæ§æ¤ç‰©æ—©æœŸé«˜æ¸©ä¿¡å·èµ·å§‹çš„åˆ†å­æœºåˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247658497&amp;idx=2&amp;sn=a38acc3754efafcec03f4ea2d010f93c">é«˜ç›Šå†›/ç‹å³°/å»–é›¯å©·/èµµé½/æ–¹å…†å…ƒç­‰Cancer Cellï¼šæ­ç¤ºç±»æ½˜æ°ç»†èƒè½¬åˆ†åŒ–é©±åŠ¨ç»“ç›´è‚ ç™Œå¯¹KRAS/EGFRåŒé¶æ²»ç–—è€è¯</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247658657&amp;idx=1&amp;sn=4b75ab2393ef4231e43fdf73bc317001">å¾®ç”Ÿç‰©ï¼šåœ°çƒå¥åº·çš„éšå½¢å®ˆæŠ¤è€… | Cell Press Live</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510197&amp;idx=4&amp;sn=dfb6e9b498b3d74e6ddacf0a5b9844fd">ä»£è°¢é‡ç¼–ç¨‹ï¼ä¸­å—å¤§å­¦æ¹˜é›…åŒ»é™¢/é¦™æ¸¯å¤§å­¦åˆä½œå‘æ–‡ï¼šæ²»ç–—è‚ºç™Œè„‘è½¬ç§»çš„ä¸€ç§æœ‰å‰æ™¯çš„ç­–ç•¥</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656510197&amp;idx=3&amp;sn=c3c75fc964798b8a6d68633174c2d8f1">å“®å–˜å’Œæ…¢æ€§é¼»çª¦ç‚ä¼´é¼»æ¯è‚‰ä¸¤ç§ç–¾ç—…ä¸ºä½•ç»å¸¸åŒæ—¶å‡ºç°ï¼Ÿè¶…75ä¸‡äººåŸºå› ç»„æ•°æ®åˆ†æï¼Œå‘ç°71ä¸ªå…±äº«åŸºå› ä½ç‚¹</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxODY4NDEwMA==&amp;mid=2247490041&amp;idx=1&amp;sn=4d6a26f8b8eea2ae75248d3c68de8ef3">åå¤§æŠ—è¡°è€ç‰©è´¨åŠå…¶ä½œç”¨æœºç†</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (75æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308299">GSE308299 ç ”ç©¶å‘ç°ï¼Œåœ¨åµå·¢ç™Œä¸´åºŠå‰æ¨¡å‹ä¸­ï¼ŒJNK æ•²ä½é€šè¿‡ NFATc1 å¢å¼º CAR-T ç»†èƒçš„ç»†èƒæ¯’æ€§ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306569">GSE306569 çƒçŠ¶ä½“åŸ¹å…»æ­ç¤ºäº†ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­ç™Œç—‡å¹²ç»†èƒçš„å¯Œé›†å’Œç‹¬ç‰¹çš„åŒ–ç–—ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306950">GSE306950 NKç»†èƒæ´»åŒ–å¤±è°ƒå’Œé«“ç³»-æ·‹å·´ç³»å¤±è¡¡æ˜¯COPDè¿›å±•çš„åŸºç¡€ï¼šæ¥è‡ªé«˜ç»´å…ç–«åˆ†æå’Œå¸çƒŸè¯±å¯¼çš„å…ç–«é‡å¡‘çš„å¯ç¤º</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298464">GSE298464 å•ç»†èƒ RNA æµ‹åºæ­ç¤ºæºƒç–¡æ€§ç»“è‚ ç‚æ‚£è€…å¯¹ TNF-Î± æŠ‘åˆ¶å‰‚æ²»ç–—çš„ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297006">GSE297006 å†…æºæ€§é€†è½¬å½•ç—…æ¯’é€šè¿‡ RIG-I é€šè·¯ä¿ƒè¿›ç³»ç»Ÿæ€§çº¢æ–‘ç‹¼ç–®ä¸­å¼‚å¸¸çš„ T ç»†èƒåˆ†åŒ– [SLE]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296556">GSE296556 å†…æºæ€§é€†è½¬å½•ç—…æ¯’é€šè¿‡ RIG-I é€šè·¯ä¿ƒè¿›ç³»ç»Ÿæ€§çº¢æ–‘ç‹¼ç–®ä¸­å¼‚å¸¸çš„ T ç»†èƒåˆ†åŒ– [mouse_CD4]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296447">GSE296447 ç‹¬ç‰¹çš„ç©ºé—´ç»„ç»‡è°ƒæ§å£è…”é»è†œå…ç–«</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292853">GSE292853 Ribo-lite æ˜¯ä¸€ç§åœ¨ä½èµ·å§‹é‡ä¸‹å¯¹æ¥å— 5+3 æˆ–è½½ä½“æ²»ç–—å¹¶å–‚é£Ÿæ ‡å‡†æ°¨åŸºé…¸ (AA) æˆ–ä¸å«æ”¯é“¾æ°¨åŸºé…¸ (BCAA) é¥®é£Ÿçš„å°é¼  AML ç»†èƒè¿›è¡Œé…å¯¹è½¬å½•ç»„ (RNA-seq) å’Œç¿»è¯‘ç»„ (Ribo-seq) åˆ†æçš„æ–¹æ³•ã€‚[II]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288272">GSE288272 å†…æºæ€§é€†è½¬å½•ç—…æ¯’é€šè¿‡ RIG-I é€šè·¯ä¿ƒè¿›ç³»ç»Ÿæ€§çº¢æ–‘ç‹¼ç–®ä¸­å¼‚å¸¸çš„ T ç»†èƒåˆ†åŒ– [å¹¼ç¨š]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283618">GSE283618 FSTL3 è¿‡è¡¨è¾¾æ˜¯è°ƒæ§åŒåŸºå› å°é¼ åµå·¢è‚¿ç˜¤å¾®ç¯å¢ƒçš„å…³é”®å› ç´ </a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280939">GSE280939 å‘ç°ä¸€ç§å°å°ºå¯¸å’ªå”‘-è‹¯å¹¶å²å“šé…ä½“ï¼Œè¯¥é…ä½“å¯ä¸ KRAS å¯åŠ¨å­ G-å››é“¾ä½“ç»“åˆï¼ŒæŠ‘åˆ¶ç™Œç—‡ç”Ÿé•¿å¹¶å¢å¼ºå…ç–«è°ƒèŠ‚ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266202">GSE266202 EZH2 æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ å˜åŒ–å¢åŠ é«˜ AID æ´»æ€§æˆ– DNA ä¿®å¤ç¼ºé™·çš„ B ç»†èƒä¸­çš„æ˜“ä½ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255082">GSE255082 é«˜è¡€å‹é€šè¿‡äº¤æ„Ÿç¥ç»æ¿€æ´»å¤–å‘¨å…ç–«ç³»ç»Ÿä¿ƒè¿›æµ·é©¬ç‚ç—‡å’Œè®¤çŸ¥éšœç¢</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231781">GSE231781 æ‚£è€…æ¥æºå®«é¢ˆç±»å™¨å®˜çš„å•ç»†èƒå›¾è°±æ­ç¤ºäº†è¡£åŸä½“æ„ŸæŸ“æœŸé—´ä¸Šçš®å…ç–«å¼‚è´¨æ€§å’Œç»†èƒé—´ç›¸äº’ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231775">GSE231775 æ‚£è€…æ¥æºå®«é¢ˆç±»å™¨å®˜çš„å•ç»†èƒå›¾è°±æ­ç¤ºäº†è¡£åŸä½“æ„ŸæŸ“æœŸé—´ä¸Šçš®å…ç–«å¼‚è´¨æ€§å’Œç»†èƒé—´ç›¸äº’ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231773">GSE231773 æ‚£è€…æ¥æºå®«é¢ˆç±»å™¨å®˜çš„å•ç»†èƒå›¾è°±æ­ç¤ºäº†è¡£åŸä½“æ„ŸæŸ“æœŸé—´ä¸Šçš®å…ç–«å¼‚è´¨æ€§å’Œç»†èƒé—´ç›¸äº’ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300915">GSE300915 éª¨å·¨å™¬ç»†èƒåå™¬ä½œç”¨è¯±å¯¼çš„ä»£è°¢è½¬å˜é©±åŠ¨ä¹³é…¸ç”Ÿæˆå¹¶è°ƒèŠ‚ç‚ç—‡å’Œç ´éª¨ç»†èƒç”Ÿæˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298405">GSE298405 åˆ©ç”¨ AAV9-ME CRISPR æ–‡åº“åœ¨å°é¼ è‚ºéƒ¨ç‚ç—‡æ¨¡å‹ä¸­ç­›é€‰å¿…éœ€ä»£è°¢ä»‹è´¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289642">GSE289642 éç»å…¸ PRC2 æŸ“è‰²è´¨å…³è”æ­ç¤º EZHIP åœ¨ä»£é™…è¡¨è§‚é—ä¼ è®°å¿†è½¬å˜ä¸­çš„å…³é”®ä½œç”¨ [ChIP-Seq, Cut & Run]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289641">GSE289641 éç»å…¸ PRC2 æŸ“è‰²è´¨å…³è”æ­ç¤º EZHIP åœ¨ä»£é™…è¡¨è§‚é—ä¼ è®°å¿†è½¬å˜ä¸­çš„å…³é”®ä½œç”¨ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228743">GSE228743 HOXB13 é€šè¿‡ä¸ SWI/SNF å¤åˆç‰©çš„ç›¸äº’ä½œç”¨æ”¹å˜å‰åˆ—è…ºç™Œä¸­çš„æŸ“è‰²è´¨å¯åŠæ€§ [ChIP-seq ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE228742">GSE228742 HOXB13 é€šè¿‡ä¸ SWI/SNF å¤åˆç‰©çš„ç›¸äº’ä½œç”¨æ”¹å˜å‰åˆ—è…ºç™Œä¸­çš„æŸ“è‰²è´¨å¯åŠæ€§ [ATAC-seq ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310403">GSE310403 æœè‡ yki è‚¿ç˜¤ç»„ç»‡ä¸¤ç§ç‰ˆæœ¬çš„ RNA æµ‹åºåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310343">GSE310343 IL-22 æ¥è‡ªè‚ å†…åˆ†æ³Œç»†èƒï¼Œé€šè¿‡å¾®ç”Ÿç‰©ç¾¤ä¿ƒè¿›æ–‘é©¬é±¼æ—©æœŸè‚ é“è •åŠ¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309795">GSE309795 é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚å¿ƒè„æ¯’æ€§çš„å¤šå°ºåº¦åˆ†ææ­ç¤ºæœºæ¢°æ•æ„Ÿç¦»å­é€šé“ PIEZO1 å…·æœ‰å¿ƒè„ä¿æŠ¤ä½œç”¨ [bulk RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297742">GSE297742 å‰åˆ—è…ºè…ºç™Œæ‚£è€…åŸå‘è‚¿ç˜¤æ´»æ£€æ ·æœ¬çš„æ‰¹é‡RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297652">GSE297652ï¼šM1æœŸå‰åˆ—è…ºç™Œæ‚£è€…è½¬ç§»ç¶æ´»æ£€å’Œå¤–å‘¨è¡€å•æ ¸ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310316">GSE310316 Nox4æŠ‘åˆ¶å‰‚æ²»ç–—å¯æ”¹å–„æœæ°è‚Œè¥å…»ä¸è‰¯ç—‡å°é¼ æ¨¡å‹çš„å¿ƒè„åŠŸèƒ½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310057">GSE310057 å¯¹ RiboCancer ç»†èƒç³»é¢æ¿çš„ç¿»è¯‘ç»„å’Œç¿»è¯‘åŠ¨åŠ›å­¦åˆ†æè¡¨æ˜ï¼Œç™½è¡€ç—…ç›¸å…³çš„ Rps15 çªå˜é€šè¿‡å¯†ç å­ç‰¹å¼‚æ€§ tRNA é€‚åº”ç¼ºé™·é‡å¡‘ç¿»è¯‘ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE251803">GSE251803 è½¬å½•å› å­ PLT å’ŒæŸ“è‰²è´¨è°ƒèŠ‚å› å­ PRC2 å’Œ JMJ703 å½¢æˆæ ¸å‡èšä½“ï¼Œä»¥ç»´æŒæ§åˆ¶æ°´ç¨»æ ¹åˆ†ç”Ÿç»„ç»‡ç»†èƒå‘½è¿çš„äºŒä»·ç»“æ„åŸŸä¸­çš„åŸºå› æŠ‘åˆ¶ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310346">GSE310346 EZH2 æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ æ”¹å˜å¢åŠ é«˜ AID æ´»æ€§æˆ– DNA ä¿®å¤ç¼ºé™·çš„ B ç»†èƒä¸­çš„æ˜“ä½ [MEC-1 ç»†èƒçš„ LAM-HTGTS ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310332">GSE310332 EVT0185 å¯¹ä¹™é…°è¾…é…¶Aä»£è°¢é…¶çš„æŠ‘åˆ¶ä½œç”¨å¯æŸå®³è‚æ˜ŸçŠ¶ç»†èƒæ´»åŒ–ï¼Œå¹¶é€†è½¬å°é¼ æ¨¡å‹ä¸­çš„MASHå’Œçº¤ç»´åŒ–[nanostring]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304764">GSE304764 æ¯ä½“è¡¥å……è›‹æ°¨é…¸è¯±å¯¼ç»µç¾Šåµæ¯ç»†èƒå’Œèƒšèƒçš„è¡¨è§‚é—ä¼ é‡å¡‘</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303874">GSE303874 æ²³å£æµ·è±šè„‘ç»„ç»‡RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302875">GSE302875 AngII åŠ ç›è¯±å¯¼çš„å°é¼ è…¹ä¸»åŠ¨è„‰ç˜¤çš„å•ç»†èƒè½¬å½•ç»„å­¦ç ”ç©¶[28 å¤©]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299152">GSE299152 æˆäººå’Œå°é¼ çœ¼è¡¨ç³–è¼çš„å•ç»†èƒå®šä½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298041">GSE298041 è‚ºä¸Šçš®æŸä¼¤æŸå®³å…ˆå¤©é˜²å¾¡å¹¶é‡ç¼–ç¨‹å·¨å™¬ç»†èƒåŠŸèƒ½ï¼Œé™ä½æ—©æœŸç»“æ ¸åˆ†ææ†èŒæ¸…é™¤ç‡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297736">GSE297736 EZH2 æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ å˜åŒ–å¢åŠ é«˜ AID æ´»æ€§æˆ– DNA ä¿®å¤ç¼ºé™·çš„ B ç»†èƒä¸­çš„æ˜“ä½ [MEC-1 ä¸­çš„ HTGTS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296068">GSE296068 ä½è¾“å…¥é‡è½¬åº§é…¶å¯åŠæŸ“è‰²è´¨æ£€æµ‹æ–¹æ³•é‰´å®šè‚è„ 1 ç»„å›ºæœ‰æ·‹å·´ç»†èƒçš„è¡¨è§‚é—ä¼ ç‰¹å¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295455">GSE295455 ä½“å¤–é‡‘é»„è‰²è‘¡è„çƒèŒåˆºæ¿€ç»µç¾Šä¹³è…ºä¸Šçš®ç»†èƒçš„é«˜é€šé‡è½¬å½•ç»„å­¦åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294437">GSE294437 HERV-K10 ä½œä¸ºè‚ç‚æ„ŸæŸ“ä¸­å…ç–«è°ƒèŠ‚çš„ä»‹è´¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293984">GSE293984 è¿æ¥çº¤æ¯›ã€åº”æ¿€ååº”å’Œè›‹ç™½è´¨ç¨³æ€å¼‚å¸¸ï¼Œä¸º RPGRIP1 è§†ç½‘è†œç±»å™¨å®˜çš„å˜å¼‚å’Œæ²»ç–—è¯„ä¼°æä¾›ä¿¡æ¯ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293982">GSE293982 è¿æ¥çº¤æ¯›ã€åº”æ¿€ååº”å’Œè›‹ç™½è´¨ç¨³æ€å¼‚å¸¸ï¼Œä¸º RPGRIP1 è§†ç½‘è†œç±»å™¨å®˜çš„å˜å¼‚å’Œæ²»ç–—è¯„ä¼°æä¾›ä¿¡æ¯ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292171">GSE292171 ç”¨æˆ–ä¸ç”¨ MLN4924 å¤„ç†çš„å·¨å™¬ç»†èƒçš„ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290428">GSE290428 æ—©æœŸé¥¥é¥¿å’Œ Hedgehog ç›¸å…³ä¿¡å·æ¿€æ´» daf-18/PTEN å’Œ lin-35/Rb ä¸‹æ¸¸çš„å…ˆå¤©å…ç–«ï¼Œå¯¼è‡´æˆå¹´ç§€ä¸½éšæ†çº¿è™«å‘è‚²ç—…ç†</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290063">GSE290063 ç•ªèŒ„æœå®é‡‡åç»UV-Cç…§å°„åçš„è½¬å½•ç»„å’Œè¡¨è§‚é—ä¼ ç‰¹å¾ä¸æœå®å“è´¨çš„ä¿æŒç›¸å…³</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286009">GSE286009 MFF æ ‡å¿—ç€å¤šå‘æ€§éª¨é«“ç˜¤çš„ä»£è°¢è„†å¼±æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284296">GSE284296 èƒ¶è´¨ç˜¤ç»†èƒç³» LN229 å’Œ U87 ä¸­ç³–RNAçš„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282762">GSE282762 è¡¨è§‚åŸºå› ç»„æ“ä½œæ­ç¤ºäº†ä½ç‚¹ç‰¹å¼‚æ€§æŸ“è‰²è´¨åŠ¨æ€ä¸åŸºå› è¡¨è¾¾ä¹‹é—´çš„å…³ç³» [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282761">GSE282761 è¡¨è§‚åŸºå› ç»„æ“ä½œæ­ç¤ºäº†ä½ç‚¹ç‰¹å¼‚æ€§æŸ“è‰²è´¨åŠ¨æ€ä¸åŸºå› è¡¨è¾¾ä¹‹é—´çš„å…³ç³» [Hi-C]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282760">GSE282760 è¡¨è§‚åŸºå› ç»„æ“ä½œæ­ç¤ºäº†ä½ç‚¹ç‰¹å¼‚æ€§æŸ“è‰²è´¨åŠ¨æ€ä¸åŸºå› è¡¨è¾¾ä¹‹é—´çš„å…³ç³» [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282486">GSE282486 æœ‰ä¸åˆ†è£‚æœŸ Polo æ ·æ¿€é…¶ 1 çš„æ‰¹é‡ ATACseq åˆ†æè¡¨æ˜ï¼Œæœ‰ä¸åˆ†è£‚æœŸè½¬å½•å’ŒæŸ“è‰²ä½“å¯åŠæ€§å¾—ä»¥ç»´æŒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267993">GSE267993 ZNHIT3 è°ƒæ§ç¿»è¯‘ä»¥ç¡®ä¿å°é¼ æ¤å…¥å‰å‘è‚² [scRNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266298">GSE266298 EZH2æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ æ”¹å˜ä¼šå¢åŠ AIDæ´»æ€§é«˜æˆ–DNAä¿®å¤ç¼ºé™·çš„Bç»†èƒçš„æ˜“ä½ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266270">GSE266270 EZH2 æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ å˜åŒ–å¢åŠ é«˜ AID æ´»æ€§æˆ– DNA ä¿®å¤ç¼ºé™·çš„ B ç»†èƒä¸­çš„æ˜“ä½ [GRO-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266267">GSE266267 EZH2 æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ æ”¹å˜ä¼šå¢åŠ  AID æ´»æ€§é«˜æˆ– DNA ä¿®å¤ç¼ºé™·çš„ B ç»†èƒçš„æ˜“ä½ [H3K27ac çš„åˆ‡å‰²å’Œæ ‡è®°]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266237">GSE266237 EZH2 æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ æ”¹å˜ä¼šå¢åŠ é«˜ AID æ´»æ€§æˆ– DNA ä¿®å¤ç¼ºé™·çš„ B ç»†èƒä¸­çš„æ˜“ä½ [LAM-HTGTS for CH12F3 cell]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266205">GSE266205 EZH2 æŠ‘åˆ¶å¼•èµ·çš„è¡¨è§‚é—ä¼ æ”¹å˜ä¼šå¢åŠ é«˜ AID æ´»æ€§æˆ– DNA ä¿®å¤ç¼ºé™·çš„ B ç»†èƒä¸­çš„æ˜“ä½ [H3K27me3 çš„åˆ‡å‰²å’Œæ ‡è®°]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261167">GSE261167 ç»†èŒRNAé€šè¿‡ç§€ä¸½éšæ†çº¿è™«çš„ç»„ç»‡é—´é€šè®¯ä¿ƒè¿›è›‹ç™½è´¨ç¨³æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310263">GSE310263 mRNA N6-ç”²åŸºè…ºè‹· (m6A) åœ¨é«˜ L-2-ç¾ŸåŸºæˆŠäºŒé…¸è‚¾ç™Œä¸­çš„ç”Ÿç‰©å­¦ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309870">GSE309870 APOBEC3B å¢å¼º PARP æŠ‘åˆ¶å‰‚æ¸…é™¤åµå·¢ç™Œå¹²ç»†èƒçš„ç–—æ•ˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300925">GSE300925 å·¨å™¬ç»†èƒä¸­ Lyn çš„è¡¨è¾¾ä¿ƒè¿› TLR æ¿€æ´»å¹¶ä»¥ä¸€ç§ä¸ä¾èµ–äºäºšå‹çš„æ–¹å¼é™åˆ¶å¢æ®–ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297645">GSE297645 å°åˆ†å­ ITK å’Œæ³› TRK æ¿€é…¶æŠ‘åˆ¶å‰‚ (PF-07245303) ç”¨äºç‰¹åº”æ€§çš®ç‚çš„æ½œåœ¨å±€éƒ¨æ²»ç–—</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289282">GSE289282 éç»å…¸ PRC2 æŸ“è‰²è´¨å…³è”æ­ç¤º EZHIP åœ¨ä»£é™…è¡¨è§‚é—ä¼ è®°å¿†è½¬æ¢ä¸­çš„å…³é”®ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273480">GSE273480 lncRNA CISTR-ACT è°ƒæ§äººå’Œå°é¼ çš„ç»†èƒå¤§å° [ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273476">GSE273476 lncRNA CISTR-ACT è°ƒæ§äººå’Œå°é¼ çš„ç»†èƒå¤§å° [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253048">GSE253048 ç¬¬11å¤©å¯¹ç…§ç»„ã€å…‰å­å’Œè´¨å­ç…§å°„ç»„å”¾æ¶²è…ºç±»å™¨å®˜çš„å•ç»†èƒæµ‹åºåˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253034">GSE253034 RNAæµ‹åºåˆ†æå¯¹ç…§ç»„ã€å…‰å­å’Œè´¨å­ç…§å°„ç»„å”¾æ¶²è…ºç±»å™¨å®˜åœ¨ç…§å°„å2å¤©å’Œ6å¤©çš„æƒ…å†µ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252164">GSE252164 ä¸»åŠ¨è„‰ç“£åæµå¾®åˆ›æ‰‹æœ¯åå¿ƒè„é‡å¡‘çš„è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310282">GSE310282 ç»“è‚ ä¸Šçš®å’Œå›ºæœ‰å±‚æ¥æºçš„ Treg çš„ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310225">GSE310225 ç²¾ç»†åŒ–çš„ç»†èƒæ´»æ€§è¡¨è¾¾ç‰¹å¾ä¸ºé‡åŒ–å•ç»†èƒæ•°æ®ä¸­çš„è‚¿ç˜¤å†…è¡¨å‹å¼‚è´¨æ€§æä¾›äº†ä¸€ä¸ªé¶å‘æ¡†æ¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309878">GSE309878 ç¥ç»å‘è‚²éšœç¢æ‚£è€…ä¸­è¡¨è§‚é—ä¼ è°ƒæ§å› å­ PHF20 çš„çº¯åˆç¼ºå¤±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309861">GSE309861 KLF5 æ§åˆ¶èƒ°è…ºç™Œä¸­ä¸äºšå‹æ— å…³çš„é«˜ç›¸äº’ä½œç”¨å¢å¼ºå­ä»¥è°ƒèŠ‚ç»†èƒå­˜æ´» [HiChIPseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309860">GSE309860 KLF5 æ§åˆ¶èƒ°è…ºç™Œä¸­ä¸äºšå‹æ— å…³çš„é«˜ç›¸äº’ä½œç”¨å¢å¼ºå­ä»¥è°ƒèŠ‚ç»†èƒå­˜æ´» [ChIPseq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299636">GSE299636 WDR5 é‡å¡‘ NANOG å‡èšä½“ä»¥é©±åŠ¨è½¬å½•ç¨‹åºå¹¶ç»´æŒå¹²ç»†èƒç‰¹æ€§ [ChIP-seq]</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-20 01:24</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week472025/ rel=tag>Week472025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-19/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-19</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-11-21/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-21</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-25/>ç§‘ç ”æ—¥æŠ¥ 2026-01-25</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-24/>ç§‘ç ”æ—¥æŠ¥ 2026-01-24</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-23/>ç§‘ç ”æ—¥æŠ¥ 2026-01-23</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-22/>ç§‘ç ”æ—¥æŠ¥ 2026-01-22</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-21/>ç§‘ç ”æ—¥æŠ¥ 2026-01-21</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (88)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (88)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>